Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2019 | Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial | LANCET ONCOLOGY |